Dr Vaidya talks to ecancertv at the 3rd ESTRO about his presentation of new analysis on the TARGIT-A trial.
The findings showed that targeted intraoperative radiotherapy plus lumpectomy is non-inferior to external-beam radiotherapy (EBRT) in preventing breast cancer recurrence.